Metraipolis › archive › dc_460beb0a0eee

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system… — Europe PMC PMID:39917625

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39917625
DOI
10.3389/fphar.2025.1462510
License (as archived)
solo-consultazione
Archived
2026-10-07T20:34:41.499Z
SHA-256 of the archived text
1dc05f803122da085327b68544d80582e97be85bf5aa70ead19261bdf9fae87c
Stable URL of this page
https://metraipolis.com/documento/dc_460beb0a0eee

How to cite

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system… — Europe PMC PMID:39917625 — Europe PMC (en), https://europepmc.org/article/MED/39917625 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_460beb0a0eee (Metraipolis archive dc_460beb0a0eee, sha256 1dc05f803122da085327b68544d80582e97be85bf5aa70ead19261bdf9fae87c)
BibTeX
@misc{dc460beb0a0eee,
  title = {A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system… — Europe PMC PMID:39917625},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39917625},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_460beb0a0eee; sha256 1dc05f803122da085327b68544d80582e97be85bf5aa70ead19261bdf9fae87c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39917625. Agents can read the archived copy with the MCP tool read_document.